222 related articles for article (PubMed ID: 34755524)
1. Cancer Risk in Nodules Detected at Follow-Up Lung Cancer Screening CT.
Hammer MM; Byrne SC
AJR Am J Roentgenol; 2022 Apr; 218(4):634-641. PubMed ID: 34755524
[No Abstract] [Full Text] [Related]
2. Malignant Nodules Detected on Lung Cancer Screening CT: Yield of Short-Term Follow-Up CT in Showing Nodule Growth.
Byrne SC; Hammer MM
AJR Am J Roentgenol; 2022 Nov; 219(5):735-741. PubMed ID: 35674352
[No Abstract] [Full Text] [Related]
3. Improved Interobserver Agreement on Lung-RADS Classification of Solid Nodules Using Semiautomated CT Volumetry.
Gierada DS; Rydzak CE; Zei M; Rhea L
Radiology; 2020 Dec; 297(3):675-684. PubMed ID: 32930652
[TBL] [Abstract][Full Text] [Related]
4. Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data.
Hammer MM; Hunsaker AR
AJR Am J Roentgenol; 2022 Sep; 219(3):397-405. PubMed ID: 35319912
[No Abstract] [Full Text] [Related]
5. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial.
Hammer MM; Palazzo LL; Kong CY; Hunsaker AR
Radiology; 2019 Nov; 293(2):441-448. PubMed ID: 31526256
[TBL] [Abstract][Full Text] [Related]
6. Lung-RADS Category 3 and 4 Nodules on Lung Cancer Screening in Clinical Practice.
Mendoza DP; Petranovic M; Som A; Wu MY; Park EY; Zhang EW; Archer JM; McDermott S; Khandekar M; Lanuti M; Gainor JF; Lennes IT; Shepard JO; Digumarthy SR
AJR Am J Roentgenol; 2022 Jul; 219(1):55-65. PubMed ID: 35080453
[No Abstract] [Full Text] [Related]
7. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
[TBL] [Abstract][Full Text] [Related]
8. Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules.
Chung K; Jacobs C; Scholten ET; Mets OM; Dekker I; Prokop M; van Ginneken B; Schaefer-Prokop CM
Eur Radiol; 2017 Nov; 27(11):4672-4679. PubMed ID: 28439653
[TBL] [Abstract][Full Text] [Related]
9. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.
van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B
Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773
[TBL] [Abstract][Full Text] [Related]
10. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of the PanCan Model and Lung-RADS to Assess Cancer Probability Among People With Screening-Detected, Solid Lung Nodules.
Sundaram V; Gould MK; Nair VS
Chest; 2021 Mar; 159(3):1273-1282. PubMed ID: 33393476
[TBL] [Abstract][Full Text] [Related]
12. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
Barbosa EJM; Yang R; Hershman M
AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
[No Abstract] [Full Text] [Related]
13. Detection of pulmonary nodules with scoutless fixed-dose ultra-low-dose CT: a prospective study.
Gheysens G; De Wever W; Cockmartin L; Bosmans H; Coudyzer W; De Vuysere S; Lefere M
Eur Radiol; 2022 Jul; 32(7):4437-4445. PubMed ID: 35238969
[TBL] [Abstract][Full Text] [Related]
14. Lung-RADS Version 1.0 versus Lung-RADS Version 1.1: Comparison of Categories Using Nodules from the National Lung Screening Trial.
Kastner J; Hossain R; Jeudy J; Dako F; Mehta V; Dalal S; Dharaiya E; White C
Radiology; 2021 Jul; 300(1):199-206. PubMed ID: 33944631
[TBL] [Abstract][Full Text] [Related]
15. Receipt of Recommended Follow-up Care After a Positive Lung Cancer Screening Examination.
Rivera MP; Durham DD; Long JM; Perera P; Lane L; Lamb D; Metwally E; Henderson LM
JAMA Netw Open; 2022 Nov; 5(11):e2240403. PubMed ID: 36326760
[TBL] [Abstract][Full Text] [Related]
16. Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules?
Chung K; Jacobs C; Scholten ET; Goo JM; Prosch H; Sverzellati N; Ciompi F; Mets OM; Gerke PK; Prokop M; van Ginneken B; Schaefer-Prokop CM
Radiology; 2017 Jul; 284(1):264-271. PubMed ID: 28339311
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
[TBL] [Abstract][Full Text] [Related]
18. Characterizing Lung-RADS category 4 lesions in a university lung cancer screening program.
Kocher Wulfeck M; Plesner S; Herndon JE; Christensen JD; Patz EF
Lung Cancer; 2023 Dec; 186():107420. PubMed ID: 37956610
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Lung-RADS Version 1.1 and Lung-RADS Version 2022 in Classifying Airway Nodules Detected at Lung Cancer Screening CT.
DeSimone AK; Byrne SC; Hammer MM
Radiol Cardiothorac Imaging; 2024 Feb; 6(1):e230149. PubMed ID: 38300115
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
